HER2 Positive Breast Cancers Active Not Recruiting Phase 3 Trials for Trastuzumab (DB00072)

Also known as: HER2 Positive Breast Cancer

IndicationStatusPhase
DBCOND0066412 (HER2 Positive Breast Cancers)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03013504A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer PatientsTreatment